PCT/1998/43 - World Intellectual Property Organization
PCT/1998/43 - World Intellectual Property Organization
PCT/1998/43 - World Intellectual Property Organization
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>43</strong>/<strong>1998</strong><br />
29 Oct/oct <strong>1998</strong> <strong>PCT</strong> Gazette - Section I - Gazette du <strong>PCT</strong> 14945<br />
(11) WO 98/47514 (13) A1<br />
(21) <strong>PCT</strong>/GB98/01178<br />
(22) 22 Apr/avr <strong>1998</strong> (22.04.<strong>1998</strong>)<br />
(25) en (26) en<br />
(31) 9708288.7 (32) 24 Apr/avr 1997<br />
(24.04.1997)<br />
(31) 9721266.6 (32) 7 Oct/oct 1997<br />
(07.10.1997)<br />
(<strong>43</strong>) 29 Oct/oct <strong>1998</strong> (29.10.<strong>1998</strong>)<br />
(33) GB<br />
(33) GB<br />
(51) 6 A61K 31/535<br />
(54) • USE OF AN NK–1 RECEPTOR ANTAGONIST<br />
AND AN SSRI FOR TREATING OBESITY<br />
• UTILISATION D’UN ANTAGONISTE DU<br />
RECEPTEUR NK–1 ET D’UN INHIBITEUR<br />
SELECTIF DE REABSORPTION DE LA<br />
SEROTONINE (SSRI) DANS LE TRAITE-<br />
MENT DE L’OBESITE<br />
(71) MERCK SHARP & DOHME LIMITED<br />
[GB/GB]; Hertford Road, Hoddesdon, Hertfordshire<br />
EN11 9BU (GB).<br />
(for all designated States except / pour tous les États<br />
désignés sauf US)<br />
(72, 75) HEFTI, Franz, Fridolin [US/GB]; Terlings<br />
Park, Eastwick Road, Harlow, Essex CM20 2QR<br />
(GB).<br />
(74) HISCOCK, Ian; Merck & Co., Inc., European Patent<br />
Dept., Terlings Park, Eastwick Road, Harlow,<br />
Essex CM20 2QR (GB).<br />
(81) AL AM AT AU AZ BA BB BG BR BY CA CH<br />
CN CU CZ DE DK EE ES FI GB GE GH GM GW<br />
HU ID IL IS JP KE KG KP KR KZ LC LK LR<br />
LS LT LU LV MD MG MK MN MW MX NO NZ<br />
PL PT RO RU SD SE SG SI SK SL TJ TM TR<br />
TT UA UG US UZ VN YU ZW; AP (GH GM KE<br />
LS MW SD SZ UG ZW); EA (AM AZ BY KG<br />
KZ MD RU TJ TM); EP (AT BE CH CY DE DK<br />
ES FI FR GB GR IE IT LU MC NL PT SE); OA<br />
(BF BJ CF CG CI CM GA GN ML MR NE SN<br />
TD TG).<br />
Published / Publiée : (c)<br />
(11) WO 98/47515 (13) A1<br />
(21) <strong>PCT</strong>/EP98/02365<br />
(22) 21 Apr/avr <strong>1998</strong> (21.04.<strong>1998</strong>)<br />
(25) en (26) en<br />
(31) MI97A000939 (32) 22 Apr/avr 1997<br />
(22.04.1997)<br />
(<strong>43</strong>) 29 Oct/oct <strong>1998</strong> (29.10.<strong>1998</strong>)<br />
(33) IT<br />
(51) 6 A61K 31/557, 31/195<br />
(54) • THE USE OF –METHYL–P–TYROSINE TO<br />
INHIBIT MELANIN PRODUCTION IN IRIS<br />
MELANOCYTES<br />
• UTILISATION D’ALPHA–METHYL–P–<br />
TYROSINE POUR INHIBER LA PRO-<br />
DUCTION DE MELANINE DANS DES<br />
MELANOCYTES DE L’IRIS<br />
(71) PHARMACIA & UPJOHN [SE/SE]; Lindhagensgatan<br />
133, S–112 87 Stockholm (SE).<br />
(for all designated States except / pour tous les États<br />
désignés sauf US)<br />
(72, 75) DRAGO, Filippo [IT/IT]; Pharmaconsult s.a.s.,<br />
Via Basile, 10, I–95124 Catania (IT).<br />
(74) MINOJA, Fabrizio; Bianchetti Bracco Minoja<br />
S.r.l., Via Rossini, 8, I–20122 Milano (IT).<br />
(81) AL AM AT AU AZ BA BB BG BR BY CA CH<br />
CN CU CZ DE DK EE ES FI GB GE GH GM GW<br />
HU ID IL IS JP KE KG KP KR KZ LC LK LR<br />
LS LT LU LV MD MG MK MN MW MX NO NZ<br />
PL PT RO RU SD SE SG SI SK SL TJ TM TR<br />
TT UA UG US UZ VN YU ZW; AP (GH GM KE<br />
LS MW SD SZ UG ZW); EA (AM AZ BY KG<br />
KZ MD RU TJ TM); EP (AT BE CH CY DE DK<br />
ES FI FR GB GR IE IT LU MC NL PT SE); OA<br />
(BF BJ CF CG CI CM GA GN ML MR NE SN<br />
TD TG).<br />
Published / Publiée : (c)<br />
(11) WO 98/47516 (13) A1<br />
(21) <strong>PCT</strong>/EP97/05716<br />
(22) 16 Oct/oct 1997 (16.10.1997)<br />
(25) en (26) en<br />
(31) <strong>PCT</strong>/IB97/00414 (32) 17 Apr/avr 1997 (33) WO<br />
(17.04.1997)<br />
(34) AL et al. / etc.<br />
(<strong>43</strong>) 29 Oct/oct <strong>1998</strong> (29.10.<strong>1998</strong>)<br />
(51) 6 A61K 31/565, 31/70<br />
(54) • COMBINATION THERAPY UTILISING<br />
17–KETOSTEROIDS AND INTERLEUKIN<br />
INHIBITORS, OR INTERLEUKIN–10 POTIO-<br />
NALLY WITH INTERLEUKIN INHIBITORS<br />
• THERAPIE COMBINEE METTANT EN AP-<br />
PLICATION DES 17–CETOSTEROIDES ET<br />
DES INHIBITEURS D’INTERLEUKINE,<br />
OU INTERLEUKINE–10 EVENTUEL-<br />
LEMENT AVEC DES INHIBITEURS<br />
D’INTERLEUKINE<br />
(71, 72) PRENDERGAST, Patrick, T. [IE/IE]; Baybush,<br />
Straffen, County Kildare (IE).<br />
(74) BARDEHLE PAGENBERG DOST ALTEN-<br />
BURG FROHWITTER GEISSLER & PART-<br />
NER; Postfach 86 06 20, D–81633 München<br />
(DE).<br />
(81) AL AM AT AU AZ BA BB BG BR BY CA CH<br />
CN CU CZ DE DK EE ES FI GB GE GH HU ID<br />
IL IS JP KE KG KP KR KZ LC LK LR LS LT<br />
LU LV MD MG MK MN MW MX NO NZ PL PT<br />
RO RU SD SE SG SI SK SL TJ TM TR TT UA<br />
UG US UZ VN YU ZW; AP (GH KE LS MW SD<br />
SZ UG ZW); EA (AM AZ BY KG KZ MD RU TJ<br />
TM); EP (AT BE CH DE DK ES FI FR GB GR<br />
IE IT LU MC NL PT SE); OA (BF BJ CF CG CI<br />
CM GA GN ML MR NE SN TD TG).<br />
(11) WO 98/47517 (13) A1<br />
(21) <strong>PCT</strong>/EP98/02361<br />
(22) 20 Apr/avr <strong>1998</strong> (20.04.<strong>1998</strong>)<br />
(25) en (26) en<br />
(31) 97201180.3 (32) 22 Apr/avr 1997 (33) EP<br />
(22.04.1997)<br />
(34) NL et al. / etc.<br />
(<strong>43</strong>) 29 Oct/oct <strong>1998</strong> (29.10.<strong>1998</strong>)<br />
(51) 6 A61K 31/565, 47/36<br />
(54) • STABILIZED TIBOLONE COMPOSITIONS<br />
• COMPOSITIONS STABILISEES A BASE DE<br />
TIBOLONE<br />
(71) AKZO NOBEL N.V. [NL/NL]; Velperweg 76,<br />
NL–6824 BM Arnhem (NL).<br />
(for all designated States except / pour tous les États<br />
désignés sauf US)<br />
(72, 75) HAAN DE, Pieter [NL/NL]; Drijvershof<br />
18, NL–53<strong>43</strong> XB Oss (NL). ROVERS, Adrianus,<br />
Cornelis, Petrus [NL/NL]; Azaleastraat<br />
9, NL–5691 SK Son (NL). LAMBREGTS–DE<br />
HURK, Theodora, Antonia, Maria [NL/NL];<br />
Gen. von Vlijmenstraat 5, NL–5463 CH Veghel<br />
(NL). ZWINKELS, Jocominus, Antonius, Maria<br />
[NL/NL]; Maxend 7, NL–5388 GH Nistelrode<br />
(NL). MORITA, Ryoichi [JP/JP]; 5–15, Higashinaka<br />
2–chome, Yamatotakada–shi, Nara 635–0065<br />
(JP).<br />
(74) KRAAK, Hajo; P.O. Box 20, NL–5340 BH Oss<br />
(NL).<br />
(81) AM AU BB BG BR CA CN CZ EE GE HU ID IS<br />
KE KG KP KR KZ LK LR LT LV MD MG MN<br />
MX NO NZ PL RO SD SG SI SK TJ TM TR TT<br />
UA UG US UZ VN; AP (GH GM KE LS MW SD<br />
SZ UG ZW); EA (AM AZ BY KG KZ MD RU TJ<br />
TM); EP (AT BE CH CY DE DK ES FI FR GB<br />
GR IE IT LU MC NL PT SE); OA (BF BJ CF CG<br />
CI CM GA GN ML MR NE SN TD TG).<br />
Published / Publiée : (c)<br />
(11) WO 98/47518 (13) A1<br />
(21) <strong>PCT</strong>/EP98/02284<br />
(22) 17 Apr/avr <strong>1998</strong> (17.04.<strong>1998</strong>)<br />
(25) de (26) de<br />
(31) 197 16 120.0 (32) 17 Apr/avr 1997 (33) DE<br />
(17.04.1997)<br />
(<strong>43</strong>) 29 Oct/oct <strong>1998</strong> (29.10.<strong>1998</strong>)<br />
(51) 6 A61K 31/715<br />
(54) • USE OF CHOLESTEROL–LOWERING<br />
AGENTS TO INFLUENCE SIGNAL TRANS-<br />
DUCTION PROCESSES IN THE CELL<br />
MEMBRANE AND IN THE PROPHYLAXIS<br />
OR TREATMENT OF PRION–ASSOCIATED<br />
DISEASES OR ALZHEIMER’S DISEASE<br />
• UTILISATION D’AGENTS HYPO–<br />
CHOLESTEROLEMIANTS POUR INFLUER<br />
SUR LES PROCESSUS DE TRANSDUCTION<br />
DE SIGNAUX AU NIVEAU DE LA MEM-<br />
BRANE CELLULAIRE, DANS LE CADRE DE<br />
LA PROPHYLAXIE OU DU TRAITEMENT<br />
DE MALADIES ASSOCIEES AUX PRIONS<br />
OU DE LA MALADIE D’ALZHEIMER<br />
(71) EUROPÄISCHES LABORATORIUM FÜR<br />
MOLEKULARBIOLOGIE (EMBL) [DE/DE];<br />
Meyerhofstrasse 1, D–69117 Heidelberg (DE).<br />
(for all designated States except / pour tous les États<br />
désignés sauf US)<br />
(72, 75) SIMONS, Kai [FI/DE]; Kleinschmidtstrasse<br />
27, D–69115 Heidelberg (DE).<br />
(74) WEICKMANN, H. et al. / etc.; Kopernikusstrasse<br />
9, D–81679 München (DE).<br />
(81) JP US; EP (AT BE CH CY DE DK ES FI FR GB<br />
GR IE IT LU MC NL PT SE).<br />
Published / Publiée : (c)<br />
(11) WO 98/47519<br />
(21) <strong>PCT</strong>/US98/08165<br />
(13) A1<br />
(22) 23 Apr/avr <strong>1998</strong> (23.04.<strong>1998</strong>)<br />
(25) en (26) en<br />
(31) 08/844,988 (32) 23 Apr/avr 1997<br />
(23.04.1997)<br />
(33) US<br />
(<strong>43</strong>) 29 Oct/oct <strong>1998</strong> (29.10.<strong>1998</strong>)<br />
(51) 6 A61K 33/06<br />
(54) • METHODS AND COMPOSITIONS FOR<br />
THE PREVENTION AND TREATMENT OF<br />
MUSCLE CRAMPS AND IMPROVING MUS-<br />
CULAR STRENGTH IN ATHLETES<br />
• METHODES DE PREVENTION ET DE<br />
TRAITEMENT DES CRAMPES MUSCU-<br />
LAIRES, PERMETTANT EGALEMENT<br />
D’AMELIORER LA FORCE MUSCULAIRE<br />
CHEZ DES ATHLETES, ET COMPOSITIONS<br />
AFFERENTES<br />
(63) US 08/844,988 (CON)<br />
23 Apr/avr 1997 (23.04.1997)